CENSALUD authorized for the new treatment without surgery center jowl with Belkyra
Belkyra Censalud papada


CENSALUD is one of the first centers in Spain authorized to make the new treatment without surgery Belkyra jowls. CENSALUD director, Dr. María Isabel Caballero, has been in Barcelona recently at the waist Belkyra, and the image is next to Dr Fernando Urdiales.

Allergan has launched Belkyra (with deoxycholic acid), an injectable and personalized treatment, the first of its therapeutic class, for those men and women who wanteliminate your double chin without undergoing surgery. Belkyra permanently destroys fat cells to improve the profile of the chin. Once destroyed, these cells can not store or accumulate fat.

A study by Allergan, 16.7% of Spanish admits having jowls and 72% of them ensures that it has a moderate-extreme degree. Of this group, 7 out of 10 recognize they are highly motivated for treatment to remove them their chins done. 3% even acknowledges that in the past did; however, half say that it was not effective and therefore still have this problem.

Gill is due to an accumulation of localized fat under the chin and affects both men and women. The main causes are genetic factors, overweight and aging.

62% of Spaniards ensures that Gill is among its 3 main aesthetic concerns in relation to his face, behind the eye bags and sagging skin. Of these, 31% confesses that Gill makes him look older and 26% say it affects you in confidence and self-assurance.

CENSALUD is a pioneer in aesthetic medicine centers in Mallorca, has a great experience and an extensive medical team to provide the best treatments.

sobre el